Literature DB >> 2649280

Immune cell functions in iron overload.

M de Sousa1.   

Abstract

A number of studies done in the last 10 years demonstrate the importance of iron in regulating the expression of T lymphoid cell surface markers, in influencing the expansion of different T cell subsets and in affecting different immune cell functions in vitro. It has been argued that some of the results obtained could be explained by the formation of iron polymers in the experimental conditions used in vitro (Soyano Fernandez & Romano, 1985). In this review the results of studies of immunological function in clinical situations of iron overload are analysed. From this analysis, it is concluded that the majority of the observations made in vitro have a counterpart in vivo, thus providing additional compelling evidence for the importance of iron as an immunoregulator.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2649280      PMCID: PMC1541876     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  52 in total

1.  [Suppression of the mixed lymphocytic reaction by autologous red cells and their constituents: a new hypothesis on the apparent tolerogeneic effect of blood transfusions during transplantation].

Authors:  P Keown; B Descamps
Journal:  C R Acad Hebd Seances Acad Sci D       Date:  1978-10-02

2.  Suggested models of ecotaxopathy in lymphoreticular malignancy. A role for iron-binding proteins in the control of lymphoid cell migration.

Authors:  M de Sousa; A Smithyman; C Tan
Journal:  Am J Pathol       Date:  1978-02       Impact factor: 4.307

Review 3.  Lymphoid cell positioning: a new proposal for the mechanism of control of lymphoid cell migration.

Authors:  M De Sousa
Journal:  Symp Soc Exp Biol       Date:  1978

4.  Impaired T-cell mitogen responses in some patients with thalassemia intermedia.

Authors:  C G Munn; A L Markenson; A Kapadia; M de Sousa
Journal:  Thymus       Date:  1981-08

5.  Lymphoid cell sets and serum immunoglobulins in patients with thalassaemia intermedia: relationship to serum iron and splenectomy.

Authors:  A Kapadia; M de Sousa; A L Markenson; D R Miller; R A Good; S Gupta
Journal:  Br J Haematol       Date:  1980-07       Impact factor: 6.998

Review 6.  Hemochromatosis: 1980 update.

Authors:  L W Powell; M L Bassett; J W Halliday
Journal:  Gastroenterology       Date:  1980-02       Impact factor: 22.682

7.  A non-transferrin-bound serum iron in idiopathic hemochromatosis.

Authors:  R G Batey; P Lai Chung Fong; S Shamir; S Sherlock
Journal:  Dig Dis Sci       Date:  1980-05       Impact factor: 3.199

Review 8.  Iron status and cellular immune competence.

Authors:  M F Good; L W Powell; J W Halliday
Journal:  Blood Rev       Date:  1988-03       Impact factor: 8.250

9.  Iron uptake and ferritin synthesis by peripheral blood leucocytes in patients with primary idiopathic haemochromatosis.

Authors:  A Jacobs; M R Summers
Journal:  Br J Haematol       Date:  1981-12       Impact factor: 6.998

10.  Differential inhibition of the MLR by iron: association with HLA phenotype.

Authors:  C F Bryan; K Nishiya; M S Pollack; B Dupont; M de Sousa
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

View more
  15 in total

1.  Diarrhoea due to cryptosporidium infection in thalassaemia major.

Authors:  J A Gledhill; J Porter
Journal:  BMJ       Date:  1990-07-28

Review 2.  Immunological effects of iron oxide nanoparticles and iron-based complex drug formulations: Therapeutic benefits, toxicity, mechanistic insights, and translational considerations.

Authors:  Ankit Shah; Marina A Dobrovolskaia
Journal:  Nanomedicine       Date:  2018-02-02       Impact factor: 5.307

3.  PCBP1 is associated with rheumatoid arthritis by affecting RNA products of genes involved in immune response in Th1 cells.

Authors:  Xue Cao; Panlong Li; Xiaojuan Song; Lipu Shi; Lijie Qin; Dong Chen; Tianshu Chu; Yanwei Cheng
Journal:  Sci Rep       Date:  2022-05-19       Impact factor: 4.996

Review 4.  Iron, anaemia, and inflammatory bowel diseases.

Authors:  C Gasche; M C E Lomer; I Cavill; G Weiss
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

5.  Clinical characteristics and management of iron overload in 631 patients with chronic transfusion dependency: results from a multicentre, observational study.

Authors:  Joan Cid; Luis Palomera; Matías Díaz; Concha Zamora; Fernando Solano
Journal:  Blood Transfus       Date:  2013-03-14       Impact factor: 3.443

Review 6.  Iron overload and immunity.

Authors:  Graça Porto; Maria De Sousa
Journal:  World J Gastroenterol       Date:  2007-09-21       Impact factor: 5.742

Review 7.  The Iron Curtain: Macrophages at the Interface of Systemic and Microenvironmental Iron Metabolism and Immune Response in Cancer.

Authors:  Angela DeRosa; Avigdor Leftin
Journal:  Front Immunol       Date:  2021-04-27       Impact factor: 7.561

8.  HFE H63D mutation frequency shows an increase in Turkish women with breast cancer.

Authors:  Aysen Gunel-Ozcan; Sibel Alyilmaz-Bekmez; Emine Nilufer Guler; Dicle Guc
Journal:  BMC Cancer       Date:  2006-02-19       Impact factor: 4.430

9.  Conditional deletion of ferritin h in mice reduces B and T lymphocyte populations.

Authors:  Liviu Vanoaica; Larry Richman; Maike Jaworski; Deepak Darshan; Sanjiv A Luther; Lukas C Kühn
Journal:  PLoS One       Date:  2014-02-21       Impact factor: 3.240

Review 10.  Iron Administration, Infection, and Anemia Management in CKD: Untangling the Effects of Intravenous Iron Therapy on Immunity and Infection Risk.

Authors:  Tomas Ganz; George R Aronoff; Carlo A J M Gaillard; Lawrence T Goodnough; Iain C Macdougall; Gert Mayer; Graça Porto; Wolfgang C Winkelmayer; Jay B Wish
Journal:  Kidney Med       Date:  2020-03-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.